Welcome to LookChem.com Sign In|Join Free

CAS

  • or

191171-49-0

Post Buying Request

191171-49-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-methyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

    Cas No: 191171-49-0

  • No Data

  • No Data

  • No Data

  • HWRK Chem
  • Contact Supplier

191171-49-0 Usage

Chemical structure

A urea derivative with a boronic ester on the benzene ring.

Usage

In organic synthesis and catalysis as a ligand for metal-mediated reactions.

Role in the Suzuki-Miyaura coupling reaction

Facilitates carbon-carbon bond formation in organic chemistry.

Participation in cross-coupling reactions

The boronic ester functionality allows it to react with aryl halides or triflates.

Use in the preparation of pharmaceuticals and agrochemicals

It is used in the production of various medications and chemicals used in agriculture.

Check Digit Verification of cas no

The CAS Registry Mumber 191171-49-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,1,7 and 1 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 191171-49:
(8*1)+(7*9)+(6*1)+(5*1)+(4*7)+(3*1)+(2*4)+(1*9)=130
130 % 10 = 0
So 191171-49-0 is a valid CAS Registry Number.

191171-49-0Relevant articles and documents

COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF

-

Paragraph 0172; 0173; 0176, (2020/05/30)

Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.

COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

-

Page/Page column 91-92, (2010/07/10)

Compounds of formula (I): wherein R1, R2, R3, L1, L2, and Y are as defined herein, are useful for the treatment or prophylaxis of conditions such as Duchenne muscular dystrophy, Becker muscular dystrophy, and cachexia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 191171-49-0